As Schools Spend Millions on Air Purifiers, Experts Warn of Overblown Claims and Harm to Children

Last summer, Global Plasma Solutions wanted to test whether the company’s air-purifying devices could kill covid-19 virus particles but could find only a lab using a chamber the size of a shoebox for its trials. In the company-funded study, the virus was blasted with 27,000 ions per cubic centimeter. In September, the company’s founder incidentally… Read More »

In Apple versus Epic Games, courtroom battle is only half the fight

But win or lose at the trial, Epic, which has pursued an aggressive public relations campaign against Apple alongside its court pleadings, may have already accomplished a major goal: Drawing Apple squarely into the global debate over whether and how massive technology companies should be regulated. Apple has mostly succeeded in staying out of the… Read More »

Vocera to buy PatientSafe Solutions, with eye toward small and mid-sized hospitals

Vocera to buy PatientSafe Solutions, with eye toward small and mid-sized hospitals Its addition will boost its ability to combine secure messages, nurse calls, checklists and other notifications within the electronic  health record at the point of care. Vocera Communications on Thursday announced its acquisition of San Diego-based PatientSafe Solutions. Terms of the deal were… Read More »

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma LAUSANNE, Switzerland–(BUSINESS WIRE) APRIL 23, 2021 — ADC Therapeutics SA (NYSE: ADCT) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynlonta (loncastuximab tesirine-lpyl) for the treatment of adult patients with relapsed or refractory (r/r) large B-cell lymphoma after… Read More »